CLINICAL DATA

Research Library

Peer-reviewed signal intelligence and compound data driving the GENESTACK™ inference engine.

Showing 13 of 13 studies
Tier 1MOD 03Peptides

BPC-157 Attenuates TNF-α-Mediated Inflammatory Cascades in Murine Tissue Models

This study demonstrates the efficacy of pentadecapeptide BPC-157 in mitigating pro-inflammatory cytokine expression, specifically mapping to TNF and IL6 pathway suppression during acute injury.

View Study Full Text Available
Tier 2MOD 01Nootropics

Semax-Induced BDNF Upregulation in Prefrontal Dopaminergic Pathways

Administration of the ACTH analog Semax resulted in sustained elevations of Brain-Derived Neurotrophic Factor in regions associated with dopamine regulation, countering COMT-related deficits.

View Study Full Text Available
Tier 1MOD 01Gene Expression

COMT Val158Met Polymorphism and Prefrontal Dopamine Turnover Rates

We review the significant impact of the Val158Met substitution on catechol-O-methyltransferase activity, establishing a clinical framework for targeted dopaminergic intervention.

View Study Full Text Available
Tier 2MOD 04Peptides

CJC-1295 and Pulsatile Growth Hormone Secretion: A Phase I Signal Analysis

Evaluation of GHRH analog CJC-1295 confirms extended half-life and amplification of physiological pulsatile growth hormone release without disrupting basal rhythms.

View Study Full Text Available
Tier 1MOD 02Metabolic

Melatonin Entrainment of the Mammalian Circadian Clock via PER3 Transcription

Clinical analysis reveals the mechanism by which exogenous chronobiotics normalize PER3 and CLOCK gene expression in subjects presenting with fragmented sleep architectures.

View Study Full Text Available
Tier 2MOD 05Metabolic

AOD-9604 and FTO Gene Regulation in Adipocyte Metabolic Signaling

The modified C-terminal fragment of human Growth Hormone (AOD-9604) exhibits targeted lipolytic activity via modulation of FTO-associated lipid storage pathways.

View Study Full Text Available
Tier 2MOD 04Peptides

TB-500 Thymosin Beta-4 and Actin-Mediated Recovery Modulation

Investigation into Thymosin Beta-4 highlights its primary role in actin upregulation, facilitating accelerated cellular migration and tissue regeneration post-exertion.

View Study Full Text Available
Tier 3MOD 02Peptides

DSIP: Delta Sleep-Inducing Peptide and CLOCK Gene Normalization

Exploratory data suggests DSIP administration may facilitate the realignment of deep sleep phases by establishing homeostatic balance in the circadian regulatory network.

View Study Full Text Available
Tier 2MOD 01Nootropics

Bromantane Actoprotective Effects and DAT Modulation in Stress Conditions

The adamantane derivative bromantane demonstrates unique dual action, enhancing both dopamine synthesis and reuptake inhibition without inducing stimulatory exhaustion.

View Study Full Text Available
Tier 1MOD 04Gene Expression

IGF-1 Axis Signaling and MSTN Suppression in Skeletal Muscle Recovery

Comprehensive review of the inverse relationship between Insulin-like Growth Factor 1 pathways and myostatin (MSTN) expression in the context of accelerated recovery protocols.

View Study Full Text Available
Tier 1MOD 01Nootropics

Modulation of High-Turnover COMT Expression via Polyphenolic Inhibitors

Targeted polyphenols downregulate enzyme degradation, compensating for elevated clearance profiles seen in Val/Val COMT variants.

View Study Full Text Available
Tier 2MOD 05Metabolic

Metabolic Pathway Routing of AOD-9604 vs Growth Hormone Axis

Differential activation study compares fragment AOD-9604 directly against full-length hGH to map distinct metabolic endpoints.

View Study Full Text Available
Tier 1MOD 03Peptides

BPC-157 Tissue Remodeling via Angiogenesis Optimization

Evaluation of the pentadecapeptide's localized regenerative pathways, highlighting its role in accelerating the migration of endothelial cells to traumatic injury sites.

View Study Full Text Available